A us distributor contacted zoll to report that a patient passed away while wearing the lifevest on (b)(6) 2022.Review of the download data, indicates the patient received three appropriate treatments during vt/vf which converted the arrythmia to a slower rhythm.At 00:24:20, the patient received the first appropriate treatment.The patient's rhythm at the time of the treatment event was vt @ 210 bpm with motion artifact.The patient's post-shock rhythm was sinus tachycardia @ 100 bpm with pvcs and motion artifact.At 00:27:23, the patient received the second appropriate treatment.The patient's rhythm at the time of the treatment event was vf with motion artifact.The patient's post-shock rhythm was vt @ 240 bpm with motion artifact.At 00:27:58, the patient received the third appropriate treatment.The patient's rhythm at the time of the treatment event was vf with motion artifact.The patient's post-shock rhythm was asystole with intermittent cardiac activity and motion artifact for 15 seconds transitioning to sinus bradycardia @ 30 bpm with pvcs and hb.At 00:47:47, electrode belt was disconnected.Patient was last seen in bradycardia.The patient passed away on (b)(6) 2022.Reporting due to post-shock asystole on third treatment.Post-shock asystole is a known and potentially adverse outcome of defibrillation therapy.
|